|Dr. Yue-Teh Jang||Chairman & CEO||N/A||N/A||N/A|
|Ms. Hui Jing Huang||VP of Fin. & Admin.||N/A||N/A||N/A|
|Dr. Yi-Ju Chen||VP of Corp. Devel.||N/A||N/A||N/A|
|Dr. Shuling Cheng||Chief Strategy Officer||N/A||N/A||N/A|
Medeon Biodesign, Inc. develops and markets medical devices in Taiwan and the United States. The company offers its products for minimally invasive surgeries in the areas of cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, nephrology, obstetrics and gynecology, urology, and plastic surgery. Medeon Biodesign, Inc. was founded in 2012 and is headquartered in Taipei, Taiwan.
Medeon Biodesign, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.